Table 1.
Variables | Cases (n = 101) |
miR-877-5p expression |
P-value | |
---|---|---|---|---|
Low (n = 53) | High (n = 48) | |||
Age | 0.940 | |||
≤60 | 53 | 28 | 25 | |
>65 | 48 | 25 | 23 | |
Tumor size | 0.849 | |||
≤3 cm | 62 | 33 | 29 | |
>3 cm | 39 | 20 | 19 | |
PSA | 0.196 | |||
≤10 ng/ml | 65 | 31 | 34 | |
>10 ng/ml | 36 | 22 | 14 | |
Surgical margin | 0.433 | |||
Negative | 72 | 36 | 36 | |
Positive | 29 | 17 | 12 | |
Prostate volume | 0.878 | |||
≤50 ml | 66 | 35 | 31 | |
>50 ml | 35 | 18 | 17 | |
TNM stage | 0.011 | |||
I–II | 54 | 22 | 32 | |
III | 47 | 31 | 16 | |
Gleason score | 0.047 | |||
≤7 | 68 | 31 | 37 | |
>7 | 33 | 22 | 11 |
PSA, prostate-specific antigen; TNM, tumor-node-metastasis; PCa, prostate cancer.